BiotechTube
Home/LiberoThera/Sakae Asanuma, CFA, MBA
SA

Sakae Asanuma, CFA, MBA

Director

LiberoThera

Therapeutic Areas

OncologyImmunology

LiberoThera Pipeline

DrugIndicationPhase
Anti-CCR8 antibodyCancer (likely solid tumors)Preclinical

Leadership Team at LiberoThera

YO
Yoichi Okumura
President & CEO
TK
Toru Kanke, Ph.D.
Director
MO
Makoto Ohori, Ph.D.
Director
SO
Shota Ozawa, Ph.D.
Director
View full LiberoThera profile